Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin

Intensification of antihyperglycaemic treatment in patients with poorly controlled type 2 diabetes mellitus who were on insulin therapy remains a difficult issue. Results from clinical trials with the sodium-glucose linked transporter (SGLT-2) inhibitor dapagliflozin as add-on therapy in patients wi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olga Yuryevna Sukhareva, Marina Vladimirovna Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2016
Materias:	diabetes mellitus type 2 insulin therapy sglt-2 inhibitor dapagliflozin Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/e17f2caabd3249238ccbbc7061e11d02
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e17f2caabd3249238ccbbc7061e11d02
record_format	dspace
spelling	oai:doaj.org-article:e17f2caabd3249238ccbbc7061e11d022021-11-14T09:00:20ZIntensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin2072-03512072-037810.14341/DM7745https://doaj.org/article/e17f2caabd3249238ccbbc7061e11d022016-01-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7745https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Intensification of antihyperglycaemic treatment in patients with poorly controlled type 2 diabetes mellitus who were on insulin therapy remains a difficult issue. Results from clinical trials with the sodium-glucose linked transporter (SGLT-2) inhibitor dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus using insulin are summarised and discussed in the article.Olga Yuryevna SukharevaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2insulin therapysglt-2 inhibitordapagliflozinNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 1, Pp 72-79 (2016)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 insulin therapy sglt-2 inhibitor dapagliflozin Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 insulin therapy sglt-2 inhibitor dapagliflozin Nutritional diseases. Deficiency diseases RC620-627 Olga Yuryevna Sukhareva Marina Vladimirovna Shestakova Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
description	Intensification of antihyperglycaemic treatment in patients with poorly controlled type 2 diabetes mellitus who were on insulin therapy remains a difficult issue. Results from clinical trials with the sodium-glucose linked transporter (SGLT-2) inhibitor dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus using insulin are summarised and discussed in the article.
format	article
author	Olga Yuryevna Sukhareva Marina Vladimirovna Shestakova
author_facet	Olga Yuryevna Sukhareva Marina Vladimirovna Shestakova
author_sort	Olga Yuryevna Sukhareva
title	Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
title_short	Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
title_full	Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
title_fullStr	Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
title_full_unstemmed	Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
title_sort	intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: perspectives of dapagliflozin
publisher	Endocrinology Research Centre
publishDate	2016
url	https://doaj.org/article/e17f2caabd3249238ccbbc7061e11d02
work_keys_str_mv	AT olgayuryevnasukhareva intensificationofglucoseloweringtreatmentinpatientswithdiabetesmellitustype2oninsulintherapyperspectivesofdapagliflozin AT marinavladimirovnashestakova intensificationofglucoseloweringtreatmentinpatientswithdiabetesmellitustype2oninsulintherapyperspectivesofdapagliflozin
_version_	1718429560368791552

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin

Ejemplares similares